Kevin J. Anstrom

Oct 30, 2024 | onlinelibrary.wiley.com | Yogesh N.V. Reddy |Javed Butler |Baylor Scott |Kevin J. Anstrom

Introduction Vericiguat, a soluble guanylate cyclase stimulator, is approved in many countries for the treatment of worsening heart failure (HF) with reduced ejection fraction (HFrEF).

Aug 14, 2024 | jamanetwork.com | Gervasio A. Lamas |Miami Beach |Kevin J. Anstrom |Ana Navas-Acien

Key PointsQuestion  Does therapy with edetate disodium (EDTA)–based chelation reduce major adverse cardiovascular events compared with placebo infusions among patients with diabetes and prior myocardial infarction (MI)? Findings  EDTA-based chelation did not reduce major adverse cardiovascular events compared with placebo infusion, with a hazard ratio of 0.93 (95% CI, 0.76-1.16; P = .53).

Aug 14, 2024 | jamanetwork.com | Gregory Curfman |Gervasio A. Lamas |Kevin J. Anstrom |Ana Navas-Acien

Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes Gervasio A. Lamas, MD; Kevin J. Anstrom, PhD; Ana Navas-Acien, MD, PhD; Robin Boineau, MD, MA; Hayley Nemeth, MS; Zhen Huang, MS; Jun Wen, MS; Yves Rosenberg, MD, MPH; Mario Stylianou, PhD; Teresa L. Z. Jones, MD; Bonnie R. Joubert, PhD, MPH; Qilu Yu, PhD; Regina M. Santella, PhD; Ana C. Mon, MPH; Francisco Ujueta, MD, MS; Esteban Escolar, MD; David M. Nathan, MD; Vivian A. Fonseca, MD; Y.

May 22, 2023 | ahajournals.org | Stephen Greene |Eric Velazquez |Kevin J. Anstrom |Robert M. Clare

Originally publishedhttps://doi.org/10.1161/CIRCULATIONAHA.123.064842Circulation. 2023;148:124–134AbstractBackground:Loop diuretics are a primary therapy for the symptomatic treatment of heart failure (HF), but whether torsemide improves patient symptoms and quality of life better than furosemide remains unknown.

May 16, 2023 | jamanetwork.com | William Wolowich |Carma Henry |Fort Lauderdale |Robert J. Mentz |Kevin J. Anstrom

Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Heart Failure Robert J. Mentz, MD; Kevin J. Anstrom, PhD; Eric L. Eisenstein, DBA; Shelly Sapp, MS; Stephen J. Greene, MD; Shelby Morgan, BSN; Jeffrey M. Testani, MD, MTR; Amanda H. Harrington, BSW; Vandana Sachdev, MD; Fassil Ketema, MSc; Dong-Yun Kim, PhD; Patrice Desvigne-Nickens, MD; Bertram Pitt, MD; Eric J. Velazquez, MD; TRANSFORM-HF Investigators; Kirkwood F.  Adams; Kunal Bhatt; Tracy  DeWald; Kelly M.